3-isobutyl-1-p-tolyl-3-aza-bicyclo[3.1.0]hexane | 909397-06-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 3-isobutyl-1-p-tolyl-3-aza-bicyclo[3.1.0]hexane
• 英文别名: 3-Azabicyclo[3.1.0]hexane, 1-(4-methylphenyl)-3-(2-methylpropyl)-；1-(4-methylphenyl)-3-(2-methylpropyl)-3-azabicyclo[3.1.0]hexane
• CAS: 909397-06-4
• 化学式: C₁₆H₂₃N
• 分子量: 229.365
• InChiKey: JBDUPEWFFKJOOS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3.1.0]hexanes
  申请人：Skolnick Phil

  公开号：US20060223875A1

  公开（公告）日：2006-10-05

  The invention provides novel 1-aryl-3-azabicyclo[3.1.0]hexanes that are active for modulating biogenic amine transport, along with compositions and methods for using these compounds to treat central nervous system disorders. Certain 1-aryl-3-azabicyclo[3.1.0]hexanes are provided that have at least one substituent on the aryl ring. In other embodiments 1-aryl-3-azabicyclo[3.1.0]hexanes are provided that have a substitution on the nitrogen at the ‘3’ position. In additional embodiments 1-aryl-3-azabicyclo[3.1.0]hexanes are provided which have one substitution on the aryl ring, as well as a substitution on the nitrogen at the ‘3’ position. The invention also provides novel methods of making aryl- and aza-substituted 1-aryl-3-azabicyclo[3.1.0]hexanes, including synthetic methods that form novel intermediate compounds of the invention for producing aryl- and aza-substituted 1-aryl-3-azabicyclo[3.1.0]hexanes.

  本发明提供了新型的1-芳基-3-氮杂双环[3.1.0]己烷，它们对生物胺转运的调节具有活性，以及使用这些化合物治疗中枢神经系统疾病的组合物和方法。提供了某些1-芳基-3-氮杂双环[3.1.0]己烷，其在芳基环上至少有一个取代基。在其他实施例中，提供了在“3”位的氮上有取代基的1-芳基-3-氮杂双环[3.1.0]己烷。在其他实施例中，提供了在芳基环上有一个取代基以及在“3”位的氮上有一个取代基的1-芳基-3-氮杂双环[3.1.0]己烷。本发明还提供了制备芳基和氮取代的1-芳基-3-氮杂双环[3.1.0]己烷的新方法，包括形成本发明的新中间化合物的合成方法，用于生产芳基和氮取代的1-芳基-3-氮杂双环[3.1.0]己烷。
• Methods and compositions for the treatment of neuropathies and related disorders
  申请人：Lippa S. Arnold

  公开号：US20070082939A1

  公开（公告）日：2007-04-12

  The present invention provides novel compositions and methods for treating symptoms associated with neuropathic disorders such as hyperalgesia, allodynia, and parasthesias, using a 1-aryl-3-azabicyclo[3.1.0] hexane. The invention further relates to the use of 1-aryl-3-azabicyclo[3.1.0] hexanes in pharmaceutical compositions and methods for treating neuropathic disorders and related symptoms in mammals. Patients amenable to treatment according to the invention include those suffering from diabetic neuropathies, post-herpetic neuralgia, trigeminal neuralgia, chronic lower back pain, sciatica, idiopathic and post-traumatic neuropathies, HIV-associated neuropathic pain, among many other neuropathic disorders and related symptoms.

  本发明提供了一种新型组合物和方法，用于治疗与神经病理性疾病相关的症状，如过度疼痛、触痛和感觉异常，使用1-芳基-3-氮杂双环[3.1.0]己烷。本发明还涉及在制药组合物中使用1-芳基-3-氮杂双环[3.1.0]己烷以及治疗哺乳动物神经病理性疾病和相关症状的方法。根据本发明可治疗的患者包括患有糖尿病神经病变、带状疱疹后遗神经痛、三叉神经痛、慢性腰痛、坐骨神经痛、特发性和创伤后神经病变、HIV相关神经病理性疼痛等许多神经病理性疾病和相关症状的患者。
• EP1874298A4
  申请人：——

  公开号：EP1874298A4

  公开（公告）日：2009-08-05
• METHODS AND COMPOSITIONS FOR PRODUCTION, FORMULATION AND USE OF 1-ARYL-3-AZABICYCLO[3,1,0]HEXANES
  申请人：DOV Pharmaceutical Inc.

  公开号：EP1874298A2

  公开（公告）日：2008-01-09
• [EN] METHODS AND COMPOSITIONS FOR PRODUCTION, FORMULATION AND USE OF 1-ARYL-3-AZABICYCLO[3.1.0] HEXANES<br/>[FR] PROCEDES ET COMPOSITIONS DE PRODUCTION, FORMULATION ET UTILISATION DE 1-ARYL-3-AZABICYCLO[3.1.0] HEXANES
  申请人：DOV PHARMACEUTICAL INC

  公开号：WO2006096810A2

  公开（公告）日：2006-09-14

  [EN] The invention provides novel l-aryl-3-azabicyclo[3.1.0] hexanes that are active for modulating biogenic amine transport, along with compositions and methods for using these compounds to treat central nervous system disorders. Certain l-aryl-3-azabicyclo[3.1.0] hexanes are provided that have at least one substituent on the aryl ring. In other embodiments l-aryl-3-azabicyclo[3.1.0] hexanes are provided that have a substitution on the nitrogen at the '3' position. In additional embodiments l-aryl-3-azabicyclo[3.1.0] hexanes are provided which have one substitution on the aryl ring, as well as a substitution on the nitrogen at the '3' position. The invention also provides novel methods of making aryl- and aza-substituted l-aryl-3-azabicyclo[3.1.0] hexanes, including synthetic methods that form novel intermediate compounds of the invention for producing aryl- and aza-substituted l-aryl-3-azabicyclo[3.1.0] hexanes.
  [FR] L'invention porte sur de nouveaux l-aryl-3-azabicyclo[3.1.0] hexanes et sur des compositions et méthodes d'utilisation de ces composés pour traiter les troubles du SNC. Certains de ces l-aryl-3-azabicyclo[3.1.0] hexanes présentent au moins une substitution sur le cycle aryle. D'autres de ces l-aryl-3-azabicyclo[3.1.0] hexanes présentent une substitution sur l'azote à la position '3'. Dans d'autres variantes, ces l-aryl-3-azabicyclo[3.1.0] hexanes présentent une substitution sur le cycle aryle, et une substitution sur l'azote à la position '3'. L'invention porte également sur de nouveaux procédés d'obtention d'l-aryl-3-azabicyclo[3.1.0] hexanes à substitution aryle et aza, dont des procédés de synthèse des nouveaux composés intermédiaires de l'invention permettant d'obtenir des l-aryl-3-azabicyclo[3.1.0] hexanes à substitution aryle et aza.